ZAI LAB LIMITED Noncash or Part Noncash Acquisition, Fixed Assets Acquired
ZAI LAB LIMITED (ZLAB) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $402.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-08-06
- ZAI LAB LIMITED noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-06-30 was -$227.00K.
- ZAI LAB LIMITED noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-03-31 was $629.00K, a 76.22% decline year-over-year.
- ZAI LAB LIMITED noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-12-31 was $18.00K.
- ZAI LAB LIMITED noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-09-30 was -$2.03M, a 1018.55% decline year-over-year.
- ZAI LAB LIMITED noncash or part noncash acquisition, fixed assets acquired for fiscal 2025 was $486.00K, a 8.24% increase from fiscal 2024.
- ZAI LAB LIMITED noncash or part noncash acquisition, fixed assets acquired for fiscal 2024 was $449.00K, a 81.85% decline from fiscal 2023.
- ZAI LAB LIMITED noncash or part noncash acquisition, fixed assets acquired for fiscal 2023 was $2.47M, a 53.05% decline from fiscal 2022.
- ZAI LAB LIMITED noncash or part noncash acquisition, fixed assets acquired for fiscal 2022 was $5.27M, a 105.18% increase from fiscal 2021.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$227.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $402.00K 10-Q · filed 2026-08-06 | $420.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.61M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $629.00K 10-Q · filed 2026-05-07 | $647.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.38M derived: sum of 3 quarters · filed 2026-05-07 | -$1.53M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.01M derived: sum of 2 quarters · filed 2026-02-26 | -$2.16M derived: sum of 3 quarters · filed 2026-08-06 | $486.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.18M derived: sum of 2 quarters · filed 2026-08-06 | $468.00K 10-Q · filed 2025-11-06 | -$1.70M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.50M 10-Q · filed 2026-08-06 | $335.00K derived: sum of 3 quarters · filed 2026-08-06 | $556.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $2.65M 10-Q · filed 2026-05-07 | $482.00K derived: sum of 2 quarters · filed 2026-05-07 | $703.00K derived: sum of 3 quarters · filed 2026-05-07 | $613.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.94M derived: sum of 2 quarters · filed 2026-02-26 | -$2.03M derived: sum of 3 quarters · filed 2026-02-26 | $449.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $131.00K derived: sum of 2 quarters · filed 2025-11-06 | $2.61M 10-Q · filed 2025-11-06 | $2.46M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.39M 10-Q · filed 2025-08-07 | $2.24M derived: sum of 3 quarters · filed 2026-02-26 | $521.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $2.48M 10-Q · filed 2025-05-08 | $2.33M derived: sum of 2 quarters · filed 2026-02-26 | $611.00K derived: sum of 3 quarters · filed 2026-02-26 | $723.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.87M derived: sum of 2 quarters · filed 2026-02-26 | -$1.76M derived: sum of 3 quarters · filed 2026-02-26 | $2.47M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.61M derived: sum of 2 quarters · filed 2024-11-12 | $2.63M 10-Q · filed 2024-11-12 | $4.66M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $4.34M 10-Q · filed 2024-08-06 | $6.38M derived: sum of 3 quarters · filed 2025-02-27 | $7.95M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $4.23M 10-Q · filed 2024-05-08 | $6.27M derived: sum of 2 quarters · filed 2025-02-27 | $7.84M derived: sum of 3 quarters · filed 2025-02-27 | $8.83M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.61M derived: sum of 2 quarters · filed 2025-02-27 | $4.60M derived: sum of 3 quarters · filed 2025-02-27 | $5.27M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.57M derived: sum of 2 quarters · filed 2023-11-07 | $3.23M 10-Q · filed 2023-11-07 | $4.00M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $993.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.66M 10-Q · filed 2023-08-07 | $2.43M derived: sum of 3 quarters · filed 2024-02-27 | $2.51M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $668.00K 10-Q · filed 2023-05-09 | $1.44M derived: sum of 2 quarters · filed 2024-02-27 | $1.52M derived: sum of 3 quarters · filed 2024-02-27 | $2.80M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $771.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $848.00K derived: sum of 2 quarters · filed 2024-02-27 | $2.13M derived: sum of 3 quarters · filed 2024-02-27 | $2.57M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.36M derived: sum of 2 quarters · filed 2022-11-09 | $1.80M 10-Q · filed 2022-11-09 | $251.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.72M 10-Q · filed 2022-08-09 | $174.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.52M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $439.00K 10-Q · filed 2022-05-10 | -$1.11M derived: sum of 2 quarters · filed 2023-03-01 | $243.00K derived: sum of 3 quarters · filed 2023-03-01 | $947.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$196.00K derived: sum of 2 quarters · filed 2023-03-01 | $508.00K derived: sum of 3 quarters · filed 2023-03-01 | $788.00K 10-K · filed 2023-03-01 | |
| 2020-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.05M derived: sum of 2 quarters · filed 2021-11-09 | $2.33M 10-Q · filed 2021-11-09 | $2.36M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $704.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $984.00K 10-Q · filed 2021-08-09 | $1.01M derived: sum of 3 quarters · filed 2022-03-01 | $1.13M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $280.00K 10-Q · filed 2021-05-10 | $308.28K derived: sum of 2 quarters · filed 2022-03-01 | $428.00K derived: sum of 3 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $28.28K derived: 10-K 12 month − 6-K 9 month · filed 2022-03-01 | $148.00K derived: sum of 2 quarters · filed 2022-03-01 | $416.00K 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $119.72K derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $387.72K 6-K · filed 2020-01-21 | |||
| 2019-06-30 | $268.00K 6-K · filed 2020-09-11 | ||||
| 2018-12-31 | $838.18K derived: 10-K 12 month − 6-K 9 month · filed 2021-03-01 | $1.71M 10-K · filed 2021-03-01 | $1.71M 20-F · filed 2019-03-29 | ||
| 2018-09-30 | $870.82K 6-K · filed 2020-01-21 | ||||
| 2017-12-31 | $414.00K 20-F · filed 2020-04-29 | $413.66K 20-F · filed 2018-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |